Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Return on Capital Employed (2024 - 2025)

Historic Return on Capital Employed for Inhibrx Biosciences (INBX) over the last 2 years, with Q3 2025 value amounting to 0.97%.

  • Inhibrx Biosciences' Return on Capital Employed rose 9100.0% to 0.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.97%, marking a year-over-year increase of 9100.0%. This contributed to the annual value of 1.63% for FY2024, which is N/A changed from last year.
  • Per Inhibrx Biosciences' latest filing, its Return on Capital Employed stood at 0.97% for Q3 2025, which was up 9100.0% from 0.89% recorded in Q2 2025.
  • Inhibrx Biosciences' Return on Capital Employed's 5-year high stood at 0.89% during Q2 2025, with a 5-year trough of 2.06% in Q4 2024.